Yongxian Zhuang

Yongxian Zhuang

Mayo Clinic - Rochester / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1341672
Mayo Clinic College of Medicine and Science
person_outline Yongxian Zhuang's MOST POPULAR ARTICLES
1-) Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27 Kip1 or p21 Cip1Y Zhuang, WK MiskiminsJournal of molecular signaling 3 (1), 1-11, 20083352008
2-) DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabineJ Yu, BO Qin, AM Moyer, S Nowsheen, T Liu, S Qin, Y Zhuang, D Liu, ...The Journal of clinical investigation 128 (6), 2376-2388, 20181452018
3-) Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivoY Zhuang, DK Chan, AB Haugrud, WK MiskiminsPloS one 9 (9), e108444, 20141422014
4-) Metformin induces both caspase-dependent and poly (ADP-ribose) polymerase-dependent cell death in breast cancer cellsY Zhuang, WK MiskiminsMolecular Cancer Research 9 (5), 603-615, 20111472011
5-) Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cellsAB Haugrud, Y Zhuang, JD Coppock, WK MiskiminsBreast cancer research and treatment 147, 539-550, 20141342014